MedTrace Logo

Intestinal Microbiota in COPD and Asthma

NCT04802317 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 149

Last updated 2023-12-06

No results posted yet for this study

Summary

The composition of the intestinal microbiota, the level of lipopolysaccharides, TMAO in the blood, and other parameters of patients with COPD (n=50), asthma (n=50) and the control (n=40) will be assessed as factors associated with exacerbations and respiratory symptoms in the prospective study (12 months).

Conditions

  • Chronic Respiratory Diseases

Interventions

DIAGNOSTIC_TEST

Identification of the composition of the intestinal microbiota

Identification of the composition of the intestinal microbiota

Sponsors & Collaborators

  • Center for Strategic Planning and Management of Biomedical Health Risks

    collaborator UNKNOWN

  • National Medical Research Center for Therapy and Preventive Medicine

    lead OTHER_GOV

Principal Investigators

  • Marina Smirnova, PhD, MD · NRCPM

Eligibility

Min Age
18 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-06-23
Primary Completion
2023-06-30
Completion
2023-12-05

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04802317 on ClinicalTrials.gov